Evidence map›Paper›PMID 35117210›Full record

ArticleTranslational cancer research2020

Expression of

Sheng-Sheng Liu, Yi Gao, Shui-Ping Yin, Lei Ye, Zi-Jian Song, Qian Liu, Song-Guo Li, Wei-Dong Du

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sheng-Sheng LiuDepartment of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, China.
Yi GaoDepartment of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, China.
Shui-Ping YinDepartment of Urology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Lei YeDepartment of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zi-Jian SongDepartment of Orthopaedics, the First People's Hospital of Xuzhou, Xuzhou, China.
Qian LiuDepartment of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, China.
Song-Guo LiDepartment of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, China.
Wei-Dong DuDepartment of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, China.
Anhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNXuzhou No.1 People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMannose receptor (MR) is an immune adhesion molecule and is mainly expressed in macrophages and nonmature dendritic cells. The ligand mannose, one of the natural ligands of MR, is a monosaccharide, which is localized in the envelope or cytoplasm of macrophages. The aim of this study was to investigate expression of MR and its ligand mannose in tumor tissues of primary advanced gastric cancer and to evaluate the predictive and prognostic value of the positive cells in gastric cancer patients.

methodsHistochemical staining for

resultsNumbers of NPL

conclusionsOccurrence of mannose and MR in tumor tissues of gastric cancer might be prognostic factors for estimating risk of gastric cancer patients.

Indexed as

CD206gastric cancermannose, Narcissus pseudonarcissus lectin (NPL)Mannose receptor (MR)prognosis

Identifiers

PMID35117210
PMCPMC8798769
OpenAlexW3084795728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.